Article
Targeting MDM2 and MDMX in Retinoblastoma
1 Nov 2007
Abstract excerpt
Retinoblastoma is the third most common form of cancer in infants, and metastatic retinoblastoma is lethal in approximately 90% of cases. Early detection and aggressive therapy has resulted in a 95% probability of survival for retinoblastoma patients in the United States. However, the United States only represents 3-4% of the retinoblastoma cases worldwide. The majority of children diagnosed with retinoblastoma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
